Perfusion Imaging of Meningioma by Using Continuous Arterial Spin-Labeling: Comparison with Dynamic Susceptibility-Weighted Contrast-Enhanced MR Images and Histopathologic Features

References

1. ↵
   Ostergaard L, Weisskoff RM, Chesler DA, et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I. Mathematical approach and statistical analysis. Magn Reson Med 1996;36:715–25

   CrossRefPubMedWeb of Science
2. ↵
   Ostergaard L, Sorensen AG, Kwong KK, et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II. Experimental comparison and preliminary results. Magn Reson Med 1996;36:726–36

   CrossRefPubMedWeb of Science
3. ↵
   Aronen HJ, Cohen MS, Belliveau JW, et al. Ultrafast imaging of brain tumors. Top Magn Reson Imaging 1993;5:14–24

   PubMed
4. ↵
   Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41–51

   PubMedWeb of Science
5. ↵
   Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791–98

   CrossRefPubMedWeb of Science
6. ↵
   Rother J, Guckel F, Neff W, et al. Assessment of regional cerebral blood volume in acute human stroke by use of single-slice dynamic susceptibility contrast-enhanced magnetic resonance imaging. Stroke 1996;27:1088–93

   Abstract/FREE Full Text
7. ↵
   Ueda T, Yuh WT, Maley JE, et al. Outcome of acute ischemic lesions evaluated by diffusion and perfusion MR imaging. AJNR Am J Neuroradiol 1999;20:983–89

   Abstract/FREE Full Text
8. ↵
   Bozzao A, Floris R, Baviera ME, et al. Diffusion and perfusion MR imaging in cases of Alzheimer disease: correlations with cortical atrophy and lesion load. AJNR Am J Neuroradiol 2001;22:1030–36

   Abstract/FREE Full Text
9. ↵
   Harris GJ, Lewis RF, Satlin A, et al. Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer disease: a promising alternative to nuclear medicine. AJNR Am J Neuroradiol 1998;19:1727–32

   Abstract
10. ↵
    Chalela JA, Alsop DC, Gonzalez-Atavales JB, et al. Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling. Stroke 2000;31:680–87

    Abstract/FREE Full Text
11. Chalela JA, Kasner SE, McGarvey M, et al. Continuous arterial spin labeling perfusion magnetic resonance imaging findings in postpartum vasculopathy. J Neuroimaging 2001;11:444–46

    CrossRefPubMed
12. ↵
    Detre JA, Alsop DC, Vives LR, et al. Noninvasive MRI evaluation of cerebral blood flow in cerebrovascular disease. Neurology 1998;50:633–41

    Abstract/FREE Full Text
13. ↵
    Alsop DC, Detre JA, Grossman M. Assessment of cerebral blood flow in Alzheimer’s disease by spin-labeled magnetic resonance imaging. Ann Neurol 2000;47:93–100

    CrossRefPubMedWeb of Science
14. ↵
    Wolf RL, Alsop DC, Levy-Reis I, et al. Detection of mesial temporal lobe hypoperfusion in patients with temporal lobe epilepsy by use of arterial spin labeled perfusion MR imaging. AJNR Am J Neuroradiol 2001;22:1334–41

    Abstract/FREE Full Text
15. ↵
    Warmuth C, Gunther M, Zimmer C. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. Radiology 2003;228:523–32

    CrossRefPubMedWeb of Science
16. ↵
    Gaa J, Warach S, Wen P, et al. Noninvasive perfusion imaging of human brain tumors with EPISTAR. Eur Radiol 1996;6:518–22

    PubMed
17. ↵
    Maccotta L, Detre JA, Alsop DC. The efficiency of adiabatic inversion for perfusion imaging by arterial spin labeling. NMR Biomed 1997;10:216–21

    CrossRefPubMed
18. ↵
    Alsop DC, Detre JA. Multisection cerebral blood flow MR imaging with continuous arterial spin labeling. Radiology 1998;208:410–16

    PubMedWeb of Science
19. ↵
    Uematsu H, Maeda M, Sadato N, et al. Blood volume of gliomas determined by double-echo dynamic perfusion-weighted MR imaging: a preliminary study. AJNR Am J Neuroradiol 2001;22:1915–19

    Abstract/FREE Full Text
20. ↵
    Ishimori Y, Kimura H, Uematsu H, et al. Dynamic T1 estimation of brain tumors using double-echo dynamic MR imaging. J Magn Reson Imaging 2003;18:113–20

    PubMed
21. ↵
    Alsop DC, Detre JA. Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metab 1996;16:1236–49

    CrossRefPubMedWeb of Science
22. ↵
    Barth M, Moser E. Proton NMR relaxation times of human blood samples at 1.5 T and implications for functional MRI. Cell Mol Biol (Noisy-le-grand) 1997;43:783–91

    PubMed
23. ↵
    Miyati T, Banno T, Mase M, et al. Dual dynamic contrast-enhanced MR imaging. J Magn Reson Imaging 1997;7:230–35

    PubMed
24. ↵
    Lia TQ, Guang CZ, Ostergaard L, et al. Quantification of cerebral blood flow by bolus tracking and artery spin tagging methods. Magn Reson Imaging 2000;18:503–12

    CrossRefPubMedWeb of Science
25. ↵
    Hunsche S, Sauner D, Schreiber WG, et al. FAIR and dynamic susceptibility contrast-enhanced perfusion imaging in healthy subjects and stroke patients. J Magn Reson Imaging 2002;16:137–46

    PubMed
26. ↵
    Donahue KM, Krouwer HG, Rand SD, et al. Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. Magn Reson Med 2000;43:845–53

    CrossRefPubMedWeb of Science
27. ↵
    Fuss M, Wenz F, Scholdei R, et al. Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence. Int J Radiat Oncol Biol Phys 2000;48:53–58

    CrossRefPubMed
28. Fuss M, Wenz F, Essig M, et al. Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy. Int J Radiat Oncol Biol Phys 2001;51:478–82

    CrossRefPubMed
29. ↵
    Weber MA, Thilmann C, Lichy MP, et al. Assessment of irradiated brain metastases by means of arterial spin-labeling and dynamic susceptibility-weighted contrast-enhanced perfusion MRI: initial results. Invest Radiol 2004;39:277–87

    CrossRefPubMed
30. ↵
    Yamaguchi T, Kanno I, Uemura K, et al. Reduction in regional cerebral metabolic rate of oxygen during human aging. Stroke 1986;17:1220–28

    Abstract/FREE Full Text
31. ↵
    Calamante F, Gadian DG, Connelly A. Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition. Magn Reson Med 2000;44:466–73

    CrossRefPubMed
32. ↵
    Fisel CR, Ackerman JL, Buxton RB, et al. MR contrast due to microscopically heterogeneous magnetic susceptibility: numerical simulations and applications to cerebral physiology. Magn Reson Med 1991;17:336–47

    PubMedWeb of Science
33. ↵
    Ye FQ, Mattay VS, Jezzard P, et al. Correction for vascular artifacts in cerebral blood flow values measured by using arterial spin tagging techniques. Magn Reson Med 1997;37:226–35

    PubMedWeb of Science
34. ↵
    Parkes LM, Tofts PS. Improved accuracy of human cerebral blood perfusion measurements using arterial spin labeling: Accounting for capillary water permeability. Magn Reson Med 2002;48:27–41

    CrossRefPubMed
35. ↵
    Werner R, Norris DG, Alfke K, et al. Continuous artery-selective spin labeling (CASSL). Magn Reson Med 2005;53:1006–12

    CrossRefPubMed
36. ↵
    Detre JA, Samuels OB, Alsop DC, et al. Noninvasive magnetic resonance imaging evaluation of cerebral blood flow with acetazolamide challenge in patients with cerebrovascular stenosis. J Magn Reson Imaging 1999;10:870–75

    CrossRefPubMedWeb of Science
37. ↵
    Wang J, Alsop DC, Li L, et al. Comparison of quantitative perfusion imaging using arterial spin labeling at 1.5 and 4.0 Tesla. Magn Reson Med 2002;48:242–54

    CrossRefPubMedWeb of Science